Satellos Bioscience Inc.
MSLE · XNASCIK 1421642fmd_07FM38QEPEPT8P1T8KC1G7E8Q5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Dec 31, 2025, 2 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Research and development | 14 | 18 |
| Operating income | (20) | (26) |
| Income before taxes | (21) | (25) |
| Income tax expense | – | 0 |
| Net income from continuing operations | – | (25) |
| Net income | (21) | (25) |